235 related articles for article (PubMed ID: 19159918)
41. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
[TBL] [Abstract][Full Text] [Related]
42. [125I]-Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution.
Jungnickel SR; Gundlach AL
Neuroscience; 2005; 131(2):407-21. PubMed ID: 15708483
[TBL] [Abstract][Full Text] [Related]
43. Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters.
Kiezun J; Kiezun M; Krazinski BE; Paukszto L; Koprowicz-Wielguszewska A; Kmiec Z; Godlewski J
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551197
[TBL] [Abstract][Full Text] [Related]
44. Expression of mRNA for galanin, galanin-like peptide and galanin receptors 1-3 in the ovine hypothalamus and pituitary gland: effects of age and gender.
Whitelaw CM; Robinson JE; Chambers GB; Hastie P; Padmanabhan V; Thompson RC; Evans NP
Reproduction; 2009 Jan; 137(1):141-50. PubMed ID: 18829943
[TBL] [Abstract][Full Text] [Related]
45. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.
Kolakowski LF; O'Neill GP; Howard AD; Broussard SR; Sullivan KA; Feighner SD; Sawzdargo M; Nguyen T; Kargman S; Shiao LL; Hreniuk DL; Tan CP; Evans J; Abramovitz M; Chateauneuf A; Coulombe N; Ng G; Johnson MP; Tharian A; Khoshbouei H; George SR; Smith RG; O'Dowd BF
J Neurochem; 1998 Dec; 71(6):2239-51. PubMed ID: 9832121
[TBL] [Abstract][Full Text] [Related]
46. Galanin, galanin receptors and drug targets.
Mitsukawa K; Lu X; Bartfai T
Cell Mol Life Sci; 2008 Jun; 65(12):1796-805. PubMed ID: 18500647
[TBL] [Abstract][Full Text] [Related]
47. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
48. Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
Smith KE; Walker MW; Artymyshyn R; Bard J; Borowsky B; Tamm JA; Yao WJ; Vaysse PJ; Branchek TA; Gerald C; Jones KA
J Biol Chem; 1998 Sep; 273(36):23321-6. PubMed ID: 9722565
[TBL] [Abstract][Full Text] [Related]
49. Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.
Kanazawa T; Misawa K; Carey TE
Expert Opin Ther Targets; 2010 Mar; 14(3):289-302. PubMed ID: 20148716
[TBL] [Abstract][Full Text] [Related]
50. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus.
Mazarati A; Lu X; Kilk K; Langel U; Wasterlain C; Bartfai T
Eur J Neurosci; 2004 Jun; 19(12):3235-44. PubMed ID: 15217380
[TBL] [Abstract][Full Text] [Related]
51. Galanin, galanin receptors, and drug targets.
Mitsukawa K; Lu X; Bartfai T
Exp Suppl; 2010; 102():7-23. PubMed ID: 21299058
[TBL] [Abstract][Full Text] [Related]
52. [The expression of galanin and galanin receptors in olfactory ensheathing cells and effects of galanin on cells proliferation].
Xia CY; Qi YT; Zhang Y; Yuan CG
Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):98-104. PubMed ID: 16011241
[TBL] [Abstract][Full Text] [Related]
53. Glyphosate-induced changes in the expression of galanin and GALR1, GALR2 and GALR3 receptors in the porcine small intestine wall.
Palus K; Chmielewska-Krzesińska M; Jana B; Całka J
Sci Rep; 2024 Apr; 14(1):8905. PubMed ID: 38632282
[TBL] [Abstract][Full Text] [Related]
54. Expression and distribution of galanin receptor subtypes in the rat carotid body.
Porzionato A; Macchi V; Barzon L; Masi G; Belloni A; Parenti A; Palù G; De Caro R
Mol Med Rep; 2010; 3(1):37-41. PubMed ID: 21472197
[TBL] [Abstract][Full Text] [Related]
55. Galanin expression is down-regulated in patients with gastric cancer.
Zhang L; Fang P; Chai C; Shao L; Mao H; Qiao D; Kong G; Dong X; Shi M; Zhang Z; Bo P
J Int Med Res; 2019 Mar; 47(3):1241-1249. PubMed ID: 30616468
[TBL] [Abstract][Full Text] [Related]
56. Regulatory Influence of Galanin and GALR1/GALR2 Receptors on Inflamed Uterus Contractility in Pigs.
Jana B; Całka J; Miciński B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203944
[TBL] [Abstract][Full Text] [Related]
57. Structural insights into galanin receptor signaling.
Jiang W; Zheng S
Proc Natl Acad Sci U S A; 2022 May; 119(21):e2121465119. PubMed ID: 35594396
[TBL] [Abstract][Full Text] [Related]
58. Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression.
Flores-Burgess A; Millón C; Gago B; Narváez M; Borroto-Escuela DO; Mengod G; Narváez JA; Fuxe K; Santín L; Díaz-Cabiale Z
Neuropharmacology; 2017 May; 118():233-241. PubMed ID: 28288814
[TBL] [Abstract][Full Text] [Related]
59. Galanin Protects Rat Cortical Astrocyte from Oxidative Stress: Involvement of GalR2 and pERK1/2 Signal Pathway.
Sun J; Xu S; Li H; Li L; Xu ZD
Mediators Inflamm; 2019; 2019():2716028. PubMed ID: 31249471
[TBL] [Abstract][Full Text] [Related]
60. Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice.
Reyes-Alcaraz A; Lee YN; Son GH; Kim NH; Kim DK; Yun S; Kim DH; Hwang JI; Seong JY
Sci Rep; 2016 Feb; 6():21453. PubMed ID: 26907960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
